Hemophilia of Georgia Inc
Hemophilia of Georgia (HoG) is a nationally and internationally recognized 501(c)(3) nonprofit organization founded in 1973, based in Sandy Springs, Georgia. The organization operates as a Hemophilia Treatment Center (HTC) providing comprehensive clinical care and psychosocial services to people with bleeding disorders throughout Georgia. HoG is the only organization of its kind in Georgia dedicated to enhancing the health and wellness of the bleeding disorder community.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$97.0M
+12.2% YoY
Annual Giving
$8.1M
+17.0% YoY
Grant Count
33
+17.9% YoY
Avg Grant Size
$245K
-0.7% YoY
Mission & Focus Areas
Mission: Hemophilia of Georgia exists so that people affected by bleeding disorders live as normally and productively as possible.
The organization's primary focus areas include:
- Diagnosis, screening, treatment, research, and education of people with bleeding disorders
- Comprehensive clinical care and psychosocial services for individuals with hemophilia, von Willebrand Disease, and other inherited bleeding disorders
- Pharmacy services providing home delivery of clotting factor and other medications at competitive prices
- Education programs and advocacy
- Research funding to pursue a cure
- Volunteer opportunities and community engagement
- Medication Therapy Management (MTM)
- Telehealth services
- Scholarships
Grantmaking
HoG makes grants to support the care and treatment of people with bleeding disorders. Recent grants include:
Ready to take the next step with Hemophilia of Georgia Inc?
Geographic Focus
Where this funder awards grants
HoG primarily serves Georgia and the Southeast region, operating as the Southeast Regional Core Center. The organization also has grantmaking activity in Florida and New York.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
As of 2024:
- Total Revenue: $34.7 million
- Total Expenses: $27.9 million
- Total Assets: $97 million
- Total Liabilities: $25.2 million
- Number of Employees: 89
A significant portion of HoG's revenues are derived from the sale of clotting factor products to people with bleeding disorders, primarily in Georgia, at prices below average wholesale prices.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $97,001,551 | $86,473,069 | $77,460,536 |
| Revenue | $34,668,177 | $28,674,349 | $26,727,211 |
| Expenses | $27,853,503 | $24,590,121 | $21,684,437 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $2,787,996 | $929,001 | $2,298,462 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
142 grants across all recorded years
Open Grants
1 open opportunity from Hemophilia of Georgia Inc
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
- Rob Maloney – Chief Executive Officer
- Vic McCarty – Chief Community Engagement Officer
The organization is guided by a volunteer Board of Directors that includes individuals who have a bleeding disorder.
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| DAVID BURNS | CHIEF GOVERNANCE OFFICER | 1 | — |
| ALEX POPE | VICE-CHIEF GOVERNANCE OFFICER | 1 | — |
| TODD RATLIFF | SECRETARY/DIRECTOR | 1 | — |
| DAN MADDOCK | DIRECTOR | 0.5 | — |
| DONNEL WARREN | DIRECTOR | 0.5 | — |
| RADIUM YAN | DIRECTOR | 0.5 | — |
| PAD NARAYANAN | DIRECTOR | 0.5 | — |
| ANDY WURTZEL | DIRECTOR | 0.5 | — |
| AMY GREENE | DIRECTOR | 0.5 | — |
| MIKE GOGAN | DIRECTOR | 0.5 | — |
| NICK BLACKMON | DIRECTOR | 0.5 | — |
| EDITH A ROSATO | CHIEF EXECUTIVE OFFICER | 40 | $622,354 |
| PAUL PERROTTI | CFO (TO 06/2023) | 40 | $219,597 |
| LIBBY ISAACK | CFO (STARTED 09/2023) | 40 | $82,767 |
| ROBERT GILLESPIE | COO (TO 05/2024) | 40 | $250,194 |
| LEIGH CARPENTER | VP - PHARMACY OPS. (TO 03/2024) | 40 | $225,180 |
| VICTOR A MCCARTY | CHIEF DEVELOPMENT OFFICER | 40 | $212,288 |
| ELIZABETH SOLOMON | CHIEF STRATEGY OFFICER | 40 | $258,440 |
| JACKIE SHIPP | VICE PRESIDENT-INFO. TECHNOLOGY | 40 | $185,574 |
| RESHAM SAHIJRAM | VICE PRESIDENT-PHARMACY OPERATIONS | 40 | $184,915 |
Recent News & Activity
Recent developments and announcements
A gift from Hemophilia of Georgia established a newly renovated Bleeding & Clotting Disorders Center at Emory
Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding & ClottingThe Georgia General Assembly recognized and commended Hemophilia of Georgia for its contributions to the community
[PDF] Georgia Section 1115 Demonstration Waiver Extension ... - MedicaidSubject Areas
Focus areas based on grantmaking activity
Related Funders
Similar funders by location and focus area
Rhedcloud Foundation Inc
DECATUR, GA
Assets
$6K
Grants
1
Total Given
$13K
Atlanta Committee for Progress Inc
ATLANTA, GA
Assets
$2.1M
Grants
1
Total Given
$15K
Atlanta Postal Credit Union
ATLANTA, GA
Assets
$2.4B
Grants
4
Total Given
$308K
Justice for Children Foundation Inc
SAVANNAH, GA
Assets
$24K
Grants
0
Total Given
—
Southeast Area Blood Bankers
PEACHTREE CITY, GA
Assets
$33K
Grants
0
Total Given
—
Courts Foundation Inc
ATLANTA, GA
Assets
$38.3M
Grants
1
Total Given
$1.6M
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Hemophilia of Georgia Inc on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities